BryanDavidKraftMDFCCP
Pulmonology • Saint Louis, MOCritical Care Medicine
Associate Professor of Medicine, Director of Medical Critical Care and Medical Intensive Care Units, Washington University School of Medicine in St. Louis
Dr. Kraft is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Barnes Jewish Hospital Plaza
Saint Louis, MO 63110Phone+1 314-747-3000- Is this information wrong?
Summary
- Dr. Kraft has a wide variety of clinical and research interests, including sepsis, pneumonia, and acute respiratory distress syndrome (ARDS), and has special expertise in rare lung diseases such as pulmonary fibrosis and pulmonary alveolar proteinosis (PAP). Dr. Kraft’s research laboratory is devoted to understanding mechanisms of acute lung injury resolution, and uses translational models and clinical patient samples to identify novel pathways of recovery. Dr. Kraft is also an active investigator in clinical trials to develop new therapies for patients with lung diseases.
Education & Training
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013- Duke University HospitalResidency, Internal Medicine, 2007 - 2010
University of Tennessee Health Science Center College of MedicineClass of 2007
Certifications & Licensure
MO State Medical License 2021 - 2025
FL State Medical License 2019 - 2023
NC State Medical License 2007 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Hyperbaric VO2max Study Start of enrollment: 2015 Feb 01
- Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS) Start of enrollment: 2015 Apr 01
- Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis Start of enrollment: 2016 Mar 21
- Join now to see all
Publications & Presentations
PubMed
- Advanced Respiratory Support Days as a Novel Marker of Mortality in COVID-19 Acute Respiratory Distress Syndrome Requiring Extracorporeal Membrane Oxygenation.Sullivan, M., Grotberg, J., Kraft, B., Pawale, A., Kotkar, K., Masood, M.> ;ASAIO Journal. 2024 Jan 23
- T-cell count and T-cell telomere length in patients with severe COVID-19.Simon Verhulst, Tsung-Po Lai, Bruce A Sullenger, Yunfei Wang, Wes Rountree, Thomas N Denny, Bryan D Kraft, Lingye Chen, Christopher W Woods, Abraham Aviv> ;Frontiers in Immunology. 2024 Jan 1
- Use of Inhaled Epoprostenol in Patients With COVID-19 Receiving Humidified, High-Flow Nasal Oxygen Is Associated With Progressive Respiratory Failure.Andrew P Michelson, Patrick G Lyons, Nguyet M Nguyen, Daniel Reynolds, Rachel McDonald, Colleen A McEvoy, Vladimir Despotovic, Steven L Brody, Marin H Kollef, Bryan D ...> ;CHEST Critical Care. 2023 Dec 1
- Join now to see all
Journal Articles
- Pulmonary Arterial Hypertension: Screening, Management, and Treatment [Internet]McCrory DC, Coeytaux RR, Schmit KM, Kraft B, Kosinski AS, Mingo AM, Vann LM, Gilstrap DL, Hargett CW, Lugogo NL, Heidenfelder BL, Posey R, Irvine RJ, Wing L, Pendergas..., Rockville (MD): Agency for Healthcare Research and Quality (US), 4/2013
Books/Book Chapters
Press Mentions
Still No Consensus on Antibiotics for Persistent Sinus InfectionFebruary 6th, 2017
Inhaled CO Is Tested as ARDS TherapyJanuary 31st, 2017
Could Carbon Monoxide Be Used to Manage Sepsis-Related Lung Injury? – an Interview with Bryan Kraft, MDFebruary 22nd, 2019
Professional Memberships
- Member
- Member
Hospital Affiliations
Barnes-Jewish HospitalSaint Louis, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
